Publisher
Games Published by Bossa Studios: Revenue & Sales Estimates
Est. catalog lifetime net (USD): $682.6KRevenue estimates for the 5 Steam games published by Bossa Studios, ranked by estimated net revenue. Available estimated lifetime net (USD): $682.6K.
Catalog Est. Lifetime Net (USD)
$682.6K
Estimates for 3 of 5 tracked games
Tracked games
5
Top Earner
Surgeon Simulator: Experience Reality
$482.4K
Coverage: 5 tracked titles; 3 with net estimates; 2 without. 4 have dedicated profiles. Missing estimates are excluded from the aggregate, not treated as known zero revenue.
Role: Publisher. These are lifetime estimates for games credited to Bossa Studios; they are not company earnings, profit, or contractual receipts. Credits may omit co-development or historical publishing arrangements. Developer and publisher identities are not merged by matching names.
Recorded release dates: 2014-10-14–2017-12-15 (may include announced dates).
Largest title accounts for 70.7% of available estimated net revenue. Coverage gaps can change this share.
Showing 1–5 of the top 5 displayed entries, from 5 tracked titles. Figures include only available estimates. Search the full catalog .
Rows 1–5 · Page 1 of 1
| # | Game | Est. lifetime net (USD) | Positive reviews (raw) | Release |
|---|---|---|---|---|
| 1 |  Surgeon Simulator: Experience Reality | $482.4K | 57%Mixed (1.2K) | Dec 5, 2016 |
| 2 |  Purrfect Date - Visual Novel/Dating Simulator | $109.5K | 60%Mixed (470) | Dec 15, 2017 |
| 3 |  Deep Dungeons of Doom | $90.6K | 78%Positive (761) | Oct 14, 2014 |
| 4 |  Worlds Adrift Island Creator | — | 84%Positive (552) | Apr 28, 2016 |
| 5 | Surgeon Simulator VR: Meet The Medic | — | 77%Positive (578) | Apr 5, 2016 |
Get real-time dashboards, historical trends, and AI-powered analysis
Explore on PlayRev(opens in new tab)Revenue and sales estimates are based on the Boxleiter method using publicly available data including Steam review counts, pricing history, and statistical modeling. Actual revenue may differ significantly. These figures are provided for informational purposes only and should not be used for financial decisions. Read the full methodology.